U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07164287) titled 'Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment' on Aug. 22.
Brief Summary: This retrospective observational study examines the effects of psychedelic-assisted psychotherapy (PAP) with lysergic acid diethylamide (LSD) or psilocybin in patients with treatment-resistant depressive, anxiety, or addictive disorders.
Data will be analyzed from patients treated at the University Hospitals of Geneva between June 2020 and April 2025 who obtained individual authorizations from the Swiss Federal Office of Public Health for use of LSD or psilocybin under compassionate use criteria.
The main objective...